Drug Approval | December 16, 2021
U.S. FDA approves Bristol Myers Squibb’s Orencia
Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant
Orencia is the first FDA-approved therapy to prevent acute graft versus host disease following hematopoietic stem cell transplant
Syngene will also build and operate a new dedicated drug development laboratory to accelerate the advancement of Amgen R&D projects
While continuing to offer its current breadth of genomic services, Biogazelle will become CellCarta's Center of Excellence for the development of complex genomic biomarker assays
Immatics to receive upfront payment of US $ 150 million and additional milestone payments of up to US $ 770 million plus tiered double-digit royalties on net product sales
Up to 100 million mRNA vaccine doses could be produced in Australia each year
Atik Cameras invests in new CCD sensor technology to create an advanced scientific and industrial imaging solution, using the Teledyne e2v CCD77-00 sensor
FDA changes inspection classification of the facility to Voluntary Action Indicated
Ichnos will receive an upfront payment of Euro 20.8 million as well as additional development and commercial milestone payments and tiered royalties based upon future global sales
Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.
Subscribe To Our Newsletter & Stay Updated
